XML 57 R45.htm IDEA: XBRL DOCUMENT v3.22.0.1
SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jan. 01, 2022
Dec. 26, 2020
Jan. 01, 2022
Dec. 26, 2020
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact $ 253,319 $ 234,905 $ 707,630 $ 632,960
Effect of exchange rates 1,014 494 4,909 (2,922)
Net revenues 259,769 240,371 728,194 645,434
Operating (loss) income 35,651 40,425 61,551 110,922
Effect of exchange rates 5,807 4,286 15,553 8,644
Amortization 12,151 7,805 35,930 24,204
Restructuring and turnaround costs (5,682) (3,143) (20,250) (11,583)
Integration and transaction costs (1,860) 0 (19,218) (3,063)
PCS2 accelerated depreciation and related costs (897) (1,146) (4,790) (4,228)
MDR and IVDR costs (2,453) (1,207) (7,171) (2,696)
Litigation-related charges (138) 0 (1,221) 0
Gain on sale of assets 0 1,115 9,603 32,613
United States        
Segment Reporting Information [Line Items]        
Net revenues 167,270 147,607 460,404 382,600
Japan        
Segment Reporting Information [Line Items]        
Net revenues 19,916 20,854 55,949 57,330
Europe        
Segment Reporting Information [Line Items]        
Net revenues 41,540 41,874 126,055 123,541
Asia        
Segment Reporting Information [Line Items]        
Net revenues 30,434 29,050 83,157 77,602
Other        
Segment Reporting Information [Line Items]        
Net revenues 609 986 2,629 4,361
Service        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 5,436 4,972 15,655 15,396
Plasma products and services        
Segment Reporting Information [Line Items]        
Net revenues 116,347 123,510 308,931 309,933
Blood Center products and services        
Segment Reporting Information [Line Items]        
Net revenues 59,440 62,787 177,118 182,687
Hospital products and services        
Segment Reporting Information [Line Items]        
Net revenues 83,982 54,074 242,145 152,814
Plasma        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 96,692 102,154 250,499 249,587
Blood Center        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 74,527 80,417 221,522 234,446
Hospital        
Segment Reporting Information [Line Items]        
Net revenues before foreign exchange impact 82,100 52,334 235,609 148,927
Operating Segments        
Segment Reporting Information [Line Items]        
Operating (loss) income 121,038 111,527 329,905 300,444
Operating Segments | Plasma        
Segment Reporting Information [Line Items]        
Operating (loss) income 51,405 52,673 128,964 129,846
Operating Segments | Blood Center        
Segment Reporting Information [Line Items]        
Operating (loss) income 34,561 36,424 103,043 108,926
Operating Segments | Hospital        
Segment Reporting Information [Line Items]        
Operating (loss) income 35,072 22,430 97,898 61,672
Corporate        
Segment Reporting Information [Line Items]        
Operating (loss) income $ 68,013 $ 63,202 $ 204,930 $ 185,005